GlassScriptPhysician profile
Christopher M Dhaem
NPI 1902805393
$1,386.99
in general payments reported to CMS, 2019-2025
17 companies · $170 in 2025
The $170 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2020: $285 · 2021: $179 · 2022: $76.50 · 2023: $137 · 2024: $385 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $692.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $692.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $392.83 | 2019-2024 | Stingray, Varithena Administration Pack |
| Abiomed | $197.33 | 2020 | |
| Shockwave Medical, INC | $148.52 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $145.70 | 2021-2022 | |
| Penumbra, INC. | $91.75 | 2024 | Indigo System |
| Medtronic, INC. | $82.64 | 2021-2025 | Corevalve Evolut R |
| Janssen Pharmaceuticals, INC | $81.74 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $63.35 | 2019 | |
| Medtronic Vascular, INC. | $39.00 | 2020 | |
| Teleflex LLC | $31.42 | 2021-2024 | Manta |
| Terumo Medical Corporation | $25.59 | 2025 | Tr Band, Angio-Seal |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.09 | 2024 | Jardiance |
| Amgen INC. | $20.08 | 2023 | Repatha |
| Livanova USA, INC. | $14.89 | 2022 | |
| Pfizer INC. | $14.52 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $11.08 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $4.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Dhaem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.